Should Drug Manufacturers - Specialty & Generic Stock SCYNEXIS Inc (SCYX) Be in Your Portfolio Monday?

The 51 rating InvestorsObserver gives to SCYNEXIS Inc (SCYX) stock puts it near the top of the Drug Manufacturers - Specialty & Generic industry. In addition to scoring higher than 75 percent of stocks in the Drug Manufacturers - Specialty & Generic industry, SCYX’s 51 overall rating means the stock scores better than 51 percent of all stocks.

SCYX has an Overall Score of 51. Find out what this means to you and get the rest of the rankings on SCYX!

See Full SCYX Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 51 means the stock is more attractive than 51 percent of stocks. These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With SCYNEXIS Inc Stock Today?

SCYNEXIS Inc (SCYX) stock has fallen -1.85% while the S&P 500 has gained 0.28% as of 10:09 AM on Monday, Nov 20. SCYX has fallen -$0.03 from the previous closing price of $1.62 on volume of 63,156 shares. Over the past year the S&P 500 is higher by 14.60% while SCYX has fallen -36.14%. SCYX earned $1.40 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 1.14. Click Here to get the full Stock Report for SCYNEXIS Inc stock.